Introduction Tetralogy of Fallot (ToF) is the most prevalent cyanotic congenital heart defect, requiring timely surgical intervention to improve survival. Two primary techniques for right ventricular outflow tract (RVOT) reconstruction are transannular patch (TAP) repair and valve-sparing (VS) surgery as a less invasive alternative. While TAP resolves pulmonary stenosis, it often results in long-term pulmonary regurgitation (PR). Objective This meta-analysis investigates the pulmonary valve annulus (PVA) z-score as a predictor for choosing VS techniques to minimize complications, mean difference and cut-off analysis. Methods A systematic review and meta-analysis were conducted across 32 studies (N=5,931) assessing preoperative PVA z-scores in patients undergoing TAP or VS RVOT reconstruction. Data extraction followed PRISMA guidelines, with statistical analyses using a random-effects model by Review Manager 5.4.1 and receiver operating characteristic (ROC) curve evaluation. Results The meta-analysis showed significantly higher preoperative PVA z-scores in the VS group (MD: 0.99). The pooled grand mean PVA z-scores were -1.48 for VS and -2.93 for TAP. ROC analysis identified a z-score threshold of -2.59 (sensitivity: 81.3%, specificity: 75%) as optimal for VS surgery. Conclusion This study establishes the PVA z-score as a robust predictor for VS approaches in ToF repair, with a proposed threshold of -2.59 and above for optimal outcomes. Adoption of VS techniques guided by standardized z-score criteria may reduce PR-associated complications and enhance long-term survival and quality of life.

The authors have declared no competing interest.

https://www.prisma-statement.org/prisma-2020-checklist

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present work are contained in the manuscript